K W Schmid

[Publishing open access thanks to DEAL agreement : Disseminate your scientific contributions as widely as possible].

G Staab, K W Schmid, 2020, Der Pathologe.

MDM2 is an important prognostic and predictive factor for platin–pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53

K W Schmid, K. Schmid, S. Ting, 2015, British Journal of Cancer.